Dr. Luc Desnoyers serves as the Vice-President of Translational Research and Discovery at Neuron23. He is leading the biomarker and diagnostics efforts to move programs from the late-stage research to clinical proof of concept.

Dr. Desnoyers has spent more than two decades in the biopharmaceutical industry. Prior to joining Neuron23, Dr. Desnoyers held different positions at CytomX Therapeutics and Genentech. Dr. Desnoyers holds a Ph.D. in Biochemistry from University of Montreal and completed his post-doctoral fellow at UT Southwestern Medical Center with Drs Brown and Goldstein. He is an inventor on 1669 patents and an author on 21 top-tier publications.